featured
Benefits of OnabotulinumtoxinA Over Sacral Neuromodulation for Refractory Overactive Bladder
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
OnabotulinumtoxinA is Preferred Over Sacral Neuromodulation for Refractory Overactive Bladder: Pro
J Urol 2017 Jan 01;197(1)11-13, DA GinsbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.